Medicare Enrolled

Dr. Annabelle Garcia, MD

Student in an Organized Health Care Education/Training Program · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1314 E SONTERRA BLVD STE 2201, San Antonio, TX 78258
2104965792
In practice since 2008 (17 years)
NPI: 1013181916 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garcia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garcia? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garcia

Dr. Annabelle Garcia is a student in an organized health care education/training program in San Antonio, TX, with 17 years in practice. Based on federal Medicare data, Dr. Garcia performed 7,199 Medicare services across 3,939 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garcia received a total of $177,442 from 60 pharmaceutical and/or device companies across 1231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garcia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 2% volume in TX$ $177,442 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,199
Medicare services
Top 2% in TX for student in an organized health care education/training program
3,939
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~423 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-142,742$5$13
Office visit, established patient (20-29 min)933$58$175
Office visit, established patient (30-39 min)820$85$248
Destruction of precancerous skin growth, 1812$35$130
Destruction of skin growths (warts/lesions), 1-14503$77$221
Skin biopsy, tangential400$62$197
New patient office visit (30-44 min)207$63$217
New patient office visit (45-59 min)150$106$321
Biopsy of related skin growth, each additional growth101$38$97
Destruction of precancer skin growth, 15 or more growths86$119$328
Drug injection, under skin or into muscle74$9$27
Office visit, established patient (10-19 min)64$37$110
Steroid injection (triamcinolone)50$1$2
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm43$117$348
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks39$458$1,321
Injection into skin growth, 1-7 growths30$33$111
Biopsy of ear28$50$188
Punch biopsy, first skin growth27$84$244
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)26$306$782
Application of light by qualified health care professional to destroy precancer skin growth24$167$445
Acne surgery15$72$226
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm14$197$593
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm11$94$477
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
9.9% medium
89.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$177,442
Total received (2018-2024)
Avg $25,349/year across 7 years
Top 0% in TX for student in an organized health care education/training program
60
Companies
1,231
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$141,970 (80.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,415 (14.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,057 (5.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$63,074
2023
$67,691
2022
$14,221
2021
$5,729
2020
$3,434
2019
$18,217
2018
$5,075

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$119,926
Regeneron Healthcare Solutions, Inc.
$10,896
Allergan, Inc.
$9,389
Almirall LLC
$8,499
Aclaris Therapeutics, Inc.
$4,741
Galderma Laboratories, L.P.
$3,198
Lilly USA, LLC
$2,029
Janssen Biotech, Inc.
$1,814
GENZYME CORPORATION
$1,544
Novartis Pharmaceuticals Corporation
$1,276
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,197
AbbVie, Inc.
$1,043
PFIZER INC.
$993
LEO Pharma Inc.
$942
Merz North America, Inc.
$858
Incyte Corporation
$742
AbbVie Inc.
$735
UCB, Inc.
$699
Janssen Scientific Affairs, LLC
$681
E.R. Squibb & Sons, L.L.C.
$640
MERZ NORTH AMERICA, INC.
$528
Sun Pharmaceutical Industries Inc.
$502
VYNE Pharmaceuticals Inc.
$490
Allergan Inc.
$445
Dermavant Sciences, Inc.
$323
Arcutis Biotherapeutics, Inc.
$319
Journey Medical Corporation
$297
GlaxoSmithKline, LLC.
$240
MAYNE PHARMA INC.
$226
EPI Health, LLC
$195
SUN PHARMACEUTICAL INDUSTRIES INC.
$178
Amgen Inc.
$177
Mayne Pharma Inc.
$164
Hill Dermaceuticals, Inc.
$149
DERMIRA, INC.
$149
Paratek Pharmaceuticals, Inc.
$117
Sandoz Inc.
$117
SANOFI-AVENTIS U.S. LLC
$114
Encore Dermatology Inc.
$103
KCI USA, Inc
$81
Celgene Corporation
$74
Mylan Pharmaceuticals Inc.
$61
Sientra, Inc.
$59
Medimetriks Pharmaceuticals, Inc.
$58
Biofrontera Inc.
$53
Promius Pharma LLC
$42
Taro Pharmaceuticals USA, Inc.
$40
Kerecis Limited
$35
REVANCE THERAPEUTICS, INC.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Merck Sharp & Dohme Corporation
$26
DUSA Pharmaceuticals, Inc.
$25
Kyowa Kirin, Inc.
$23
Blueprint Medicines Corporation
$20
Mission Pharmacal Company
$20
Nabriva Therapeutics, plc
$19
ConvaTec Inc.
$19
MIMEDX Group, Inc.
$18
MAYNE PHARMA COMMERCIAL LLC
$14
KCI USA, Inc.
$14
Top 3 companies account for 79.0% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADAPTIC · ADBRY · AKLIEF · ALTRENO · AMZEEQ · APEXICON E · ARAZLO · Absorica LD · Aczone · Ameluz · Avar · BENLYSTA · BLU-U · BOTOX · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · Cloderm Cream · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Exelderm · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INNOVAMATRIX AC · Ilumya · Impoyz · JUBLIA · KERRACEL AG · KERYDIN · Kerecis Omega3 SurgiClose · LEXETTE · NO PRODUCT DISCUSSED · NUZYRA · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · PICATO · POTELIGEO · QBREXZA · REMICADE · RHOFADE · RINVOQ · SEYSARA · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TWYNEO · TargaDox · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · Veltin · Winlevi · XEOMIN · ZEPBOUND · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for student in an organized health care education/training program in TX.

Equivalent to $2,465 per 100 Medicare services performed
Looking for a student in an organized health care education/training program in San Antonio?
Compare student in an organized health care education/training programs in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an Organized Health Care Education/Training Programs within 10 mi
2,344
Per 100K population
115.1
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garcia is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 0%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garcia experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Garcia performed 2,742 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garcia receive payments from pharmaceutical companies?
Yes. Dr. Garcia received a total of $177,442 from 60 companies across 1,231 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garcia's costs compare to other student in an organized health care education/training programs in San Antonio?
Dr. Garcia's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garcia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →